← All Synaptogenix, INC filings

Synaptogenix, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

BTS
SNPX
Synaptogenix, INC
DEF: TAO Synergies Seeks Shareholder Approval for Key Financing, Equity Plan Expansion
TAO Synergies Inc. calls for its 2025 annual meeting to vote on a director election, authorization of common stock issuance for a recent financing, an increase in its equity incentive plan, and auditor ratification.
BTS
SNPX
Synaptogenix, INC
DEFA14A: TAO Synergies Inc. Supplements Proxy Statement, Details New Stock Option Awards and Voting Updates
TAO Synergies Inc. issued a supplement to its definitive proxy statement, detailing new stock option awards for board and management and clarifying voting procedures for its upcoming August 6, 2025 Special Meeting.
BTS
SNPX
Synaptogenix, INC
DEF: TAO Synergies Seeks Shareholder Approval for Major Dilutive Financing and Expanded Equity Plan to Fund AI Crypto Strategy
TAO Synergies Inc. is seeking stockholder approval for a significant dilutive financing transaction to fund a new AI cryptocurrency treasury strategy and to expand its equity incentive plan, with a special meeting scheduled for August 6, 2025.
BTS
SNPX
Synaptogenix, INC
DEFA14A: Synaptogenix Issues Corrected Proxy Card After Error in Director Nominee Listing
Synaptogenix has issued a supplemental proxy statement and corrected proxy card due to an error in the original proxy card which incorrectly listed director nominees.
BTS
SNPX
Synaptogenix, INC
DEF 14A: Synaptogenix Seeks Stockholder Approval for Share Issuance, Director Elections, and Equity Plan Amendment at Upcoming Annual Meeting
Synaptogenix is holding its 2024 annual meeting of stockholders on December 6, 2024, to vote on director elections, a share issuance proposal, an equity incentive plan amendment, and ratification of the company's accounting firm.